Drugs / Emtricitabine / Tenofovir Disoproxil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04329442 | Apr 2020 → Jul 2021 | HIV infectious disease | University of Chicago | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Emtricitabine / Tenofovir Disoproxil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04329442 ↗ |
| Route | Oral | “Emtricitabine / Tenofovir Disoproxil Oral Tablet” NCT04329442 ↗ |